The Clinical Safety and Efficacy of Cytarabine and Daunorubicin Liposome (CPX‐351) in Acute Myeloid Leukemia Patients: A Systematic Review
ABSTRACT Background Acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis when treated using conventional chemotherapy. CPX‐351, a liposomal formulation of cytarabine and daunorubicin, has demonstrated potential as a novel therapeutic strategy. Aim This systematic review a...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Cancer Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cnr2.70199 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|